KRAS and cancer: In contrast, transcriptional changes associated with both E2F targets and the G2M checkpoint were regulated by SOS2KO but not acute SOS1i treatment, consistent with previous studies showing a role for SOS2 in 3D spheroid growth of KRAS-mutated cancer cells (55,56).